| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/12/2009 | US20090069319 Imidazopyridine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 03/12/2009 | US20090069305 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor |
| 03/12/2009 | US20090069246 Methods for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 03/12/2009 | US20090068289 Formulation for menopausal women |
| 03/12/2009 | US20090068285 Calcium phosphate-based materials containing zinc, magnesium, fluoride and carbonate |
| 03/12/2009 | US20090068150 Lactic acid bacteria culture of mung bean and the preparation method of the same, and the cosmetic composition comprising the same |
| 03/12/2009 | US20090068139 LOOP PEPTIDE AND TGF alpha FOR STIMULATING STEM CELL PROLIFERATION AND MIGRATION |
| 03/12/2009 | CA2698747A1 Estrogenic extracts of scuttelaria barbata d. don of the labiatae family and uses thereof |
| 03/12/2009 | CA2698665A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation |
| 03/12/2009 | CA2698396A1 Interferon alpha2a modified by polyethylene glycol, the preparation and use thereof |
| 03/12/2009 | CA2698173A1 Interferon alpha 2b modified by polyethylene glycol, the preparation and use thereof |
| 03/11/2009 | EP2034009A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects basing on cd3/cd28 costimulation |
| 03/11/2009 | EP2033972A1 Screening method for candidate drugs |
| 03/11/2009 | EP2033660A1 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion |
| 03/11/2009 | EP2033650A1 Inhibitor of expression of nuclear transcription factor ap-1, and pharmaceutical product and product using the inhibitor |
| 03/11/2009 | EP2032584A2 Thiadiazole compounds and methods of use thereof |
| 03/11/2009 | EP2032535A1 Spirocyclic nitriles as protease inhibitors |
| 03/11/2009 | EP2032136A1 Compositions and kits comprising a melatonin component and a chondroprotective component |
| 03/11/2009 | EP1656374B1 Thiazole derivatives as npy antagonists |
| 03/11/2009 | EP1516624B1 Method of producing calcium gluconolactate, compositions, processes and uses of same |
| 03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 03/11/2009 | EP1294384B1 Use of lanthanum compounds for the treatment of bone diseases |
| 03/11/2009 | EP1268799B1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 03/11/2009 | EP1173567B1 Tribonectins |
| 03/11/2009 | EP0988374B1 Hydrophilic composition containing protease produced by vibrio proteolyticus |
| 03/11/2009 | EP0741784B1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
| 03/11/2009 | CN101384707A A method for osteogenic differentiation of bone marrow stem cells (BMSC) and uses thereof |
| 03/11/2009 | CN101384619A Modulation of bone formation |
| 03/11/2009 | CN101384595A Salt of CD 80 antagonist |
| 03/11/2009 | CN101384567A Diphenylurea derivatives and their use as chloride channel blockers or BKcA channel modulators |
| 03/11/2009 | CN101384275A Dissolution aids for oral peptide delivery comprising a biguanide |
| 03/11/2009 | CN101380457A Traditional Chinese medicine composition for treating rheumatic arthritis |
| 03/11/2009 | CN101380453A Oral powder and external plaster for treating hyperosteogeny and atrophic arthritis and production method thereof |
| 03/11/2009 | CN101380425A Arthrosis pill and production method thereof |
| 03/11/2009 | CN101380424A Knee-protection health-care medicinal pad |
| 03/11/2009 | CN101380419A Traditional Chinese medicine composition for treating scapulohumeral periarthritis and quality control method thereof |
| 03/11/2009 | CN101380416A Medicine composition for treating osteoporosis and hyperosteogeny |
| 03/11/2009 | CN101380414A Traditional Chinese medicine composition for treating gout and hyperuricemia and preparation method thereof |
| 03/11/2009 | CN101380407A Externally used Chinese herbal medicine liquor for treating hyperosteogeny |
| 03/11/2009 | CN101380400A Traditional Chinese medicine spraying-liniment for treating osteoarthrosis |
| 03/11/2009 | CN101380375A External traditional Chinese medicine preparation for treating bone and soft tissue injury and preparation method thereof |
| 03/11/2009 | CN101380374A External steaming and washing medicine for treating cervical vertebra disease |
| 03/11/2009 | CN101380372A Pharmaceutical composition for treating cervical vertebra disease and its preparation method |
| 03/11/2009 | CN101380371A Manufacture method of prepared Chinese medicament for treating cervical vertebra disease |
| 03/11/2009 | CN101380367A Traditional Chinese medicine composition for treating rheumatoid arthritis |
| 03/11/2009 | CN101380366A Medicine for treating hyperosteogeny and preparation method of preparation thereof |
| 03/11/2009 | CN101380362A Quality control method of volatile ingredients fingerprint of bone knitting medicine of traumatology |
| 03/11/2009 | CN101380361A Medicine for treating rheumatic arthritis and preparation method thereof |
| 03/11/2009 | CN101380359A Jiangu capsules and preparation method thereof |
| 03/11/2009 | CN100467450C Anthranilic acid amides and pharmaceutical use thereof |
| 03/11/2009 | CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 03/11/2009 | CN100467060C Intratumorally administered lactoferrin in the treatment of malignant neoplasms diseases |
| 03/11/2009 | CN100467059C Use of lactoferrin in the treatment of malignant neoplasms diseases |
| 03/11/2009 | CN100467056C Ointment for unblocking collaterals and relieving pain and preparation process threreof |
| 03/11/2009 | CN100467043C Chinese medicine for treating osteoporosis and its preparation |
| 03/10/2009 | US7501516 3-Cyanoquinolines 4-substituted by a methylenedioxyphenyl group that is attached by a methylene, oxy, thio, sulfinyl, sulfonyl or amino group; antitumor agents |
| 03/10/2009 | US7501485 Wound heraling agents; polypeptide |
| 03/10/2009 | US7501441 for treating uterine fibroid disease; [2-(4-hydroxyphenyl)-6-hydroxynaphthalen-1-yl][4-(2-(1-piperidinyl)ethoxy)phenyl]methane; therapy for post manupausal women |
| 03/10/2009 | US7501437 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 03/10/2009 | US7501426 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
| 03/10/2009 | US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/10/2009 | US7501407 Amide substituted pyrimidine compound; antiarthritic agents; antiischemic agents; antidiabetic agents; inflammatory bowel disease; antiproliferative agents; antiallergens |
| 03/10/2009 | US7501399 Immunoeffector compounds |
| 03/10/2009 | US7501115 Providing a tissue removal system; removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; processing at least a part of the adipose tissue to obtain a concentration |
| 03/10/2009 | CA2289851C Compounds and methods for the inhibition of the expression of vcam-1 |
| 03/05/2009 | WO2009029609A1 Imidazopyridine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 03/05/2009 | WO2009027475A1 Phenylisoquinoline and phenylquinazoline derivatives for the treatment of bone diseases |
| 03/05/2009 | WO2009027292A1 Carbonylamino derivatives useful for the treatment of certain inflammatory disorders |
| 03/05/2009 | WO2009027264A1 Benzimidazole derivatives used as fxr agonists |
| 03/05/2009 | WO2009027003A1 Use of gestagens in combination with (6s)-5-methyltetrahydrofolate for the therapy of endometriosis with simultaneous reduction of therapy side effects and the reduction of the risk of congenital malformations in case of pregnancy |
| 03/05/2009 | WO2009026705A1 Method of diagnosing and treating osteoarthritis |
| 03/05/2009 | WO2009010479A3 Heterocyclic methylene piperidine derivatives and their use |
| 03/05/2009 | WO2009007747A3 Hydantoin derivatives used as mmp12 inhibitors |
| 03/05/2009 | WO2008156685A3 Tendon stem cells |
| 03/05/2009 | WO2008152334A3 Novel derivatives of 3-phenyl acrylic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions |
| 03/05/2009 | WO2008023258A8 Piperidine derivatives |
| 03/05/2009 | US20090062374 Deuterium-enriched lasofoxifene |
| 03/05/2009 | US20090062364 Deuterium-enriched celecoxib |
| 03/05/2009 | US20090062322 Novel Tricyclic Spiropiperidines or Spiropyrrolidines |
| 03/05/2009 | US20090062320 Method of Treating Disorders Mediated by the Fibroblast Growth Factor Receptor |
| 03/05/2009 | US20090062201 Integrin binding motif containing peptides and methods of treating skeletal diseases |
| 03/05/2009 | US20090060999 Protein formulation |
| 03/05/2009 | US20090060988 Nell-1 enhanced bone mineralization |
| 03/05/2009 | US20090060974 Methods of arthroscopic osteochondral resurfacing |
| 03/05/2009 | US20090060953 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 03/05/2009 | US20090060924 having high affinity and strong neutralizing properties; increasing bone mass, bone mineral density and bone strength and for the treatment of various disorders, e.g. osteoporosis |
| 03/05/2009 | US20090060918 Method of treating or preventing an IL-1 related disease or condition |
| 03/05/2009 | US20090060909 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 03/05/2009 | US20090060900 Methods for Screening Compounds That Modulate Lipid Metabolism |
| 03/05/2009 | US20090060885 Composition For Treatment of Articular Cartilage Damage |
| 03/05/2009 | US20090060884 Concentration of stem cells obtained during orthopaedic surgeries |
| 03/05/2009 | US20090060883 Composition for promotion of bone growth and maintenance of bone health |
| 03/05/2009 | US20090060865 Mammalian receptor proteins; related reagents and methods |
| 03/05/2009 | DE102007040336A1 Neue Inhibitoren der 5-Lipoxygenase und deren Verwendungen New inhibitors of 5-lipoxygenase and their uses |
| 03/05/2009 | CA2698071A1 Imidazopyridine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 03/05/2009 | CA2697885A1 An apparatus and method for treatment and prevention of infectious disease |
| 03/05/2009 | CA2697167A1 Benzimidazole derivatives used as fxr agonists |
| 03/05/2009 | CA2696030A1 Use of gestagens in combination with (6s)-5-methyltetrahydrofolate for therapy of endometriosis with simultaneous reduction of therapy side effects and reduction of the risk of congenital abnormalities at the onset of a pregnancy |
| 03/04/2009 | EP2031057A1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |